Trends in immunotherapy use and survival impact in stage IV non-small cell lung cancer.

被引：0
|
作者：
Otaibi, Zachary
Kamran, Amir
Wegner, Rodney E.
Colonias, Athanasios
Weksler, Benny
Finley, Gene Grant
机构：
[1] Allegheny Hlth Network, Pittsburgh, PA USA
[2] Allegheny Hlth Network, Inst Canc, Pittsburgh, PA USA
[3] Allegheny Hlth Network, Inst Canc, Div Radiat Oncol, Pittsburgh, PA USA
[4] Allegheny Gen Hosp, Sewickley, PA USA
[5] Allegheny Hlth Network, Dept Cardiothorac Surg, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20715
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Survival Improvement of Stage IV Non-small Cell Lung Cancer in the Immunotherapy Era: A Retrospective Cohort Study in a US Population
    Lianfang Ni
    Zhigang Zhang
    Dan Sun
    Zhonghui Liu
    Xinmin Liu
    Advances in Therapy, 2024, 41 (12) : 4591 - 4600
  • [32] Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer
    Fung, A.
    D'Silva, A.
    Li, H.
    Otsuka, S.
    Bebb, D. G.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2077 - S2078
  • [33] Clinicopathologic Characteristics And Predictors Of Survival In Stage Iv Non-Small Cell Lung Cancer (nsclc)
    Duma, N.
    Listo, M.
    Osorio, C.
    Zhang, S.
    Kang, M.
    Abu-Ihweij, K.
    Harper, H.
    Gutierrez, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [34] Characteristics Impacting Overall Survival in Stage IV Non-Small Cell Lung Cancer Patients
    Iyer, S.
    Biswas, T.
    Kharouta, M. Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E376 - E376
  • [35] Predictors of erlotinib utilization and the impact of erlotinib use on overall survival in advanced, non-small cell lung cancer.
    Ersek, Jennifer L.
    Symanowski, James Thomas
    Kim, Edward S.
    Adams, Swann Arp
    Hebert, James R.
    Eberth, Jan Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
  • [37] The impact of histologic subtype and stage on survival in patients with non-small cell lung cancer
    Cai, X. W.
    Xu, L.
    Wang, L.
    Hayman, J.
    Cease, K.
    Pickens, A.
    Orringer, N.
    Brenner, D.
    Kalemkerian, G.
    Kong, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S458 - S458
  • [38] Personal and clinical characteristics associated with immunotherapy effectiveness in stage IV non-small cell lung cancer
    Patel, Krishna H.
    Alpert, Naomi
    Tuminello, Stephanie
    Taioli, Emanuela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (06) : 1210 - +
  • [39] Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era
    Kehl, Kenneth L.
    Hassett, Michael J.
    Schrag, Deborah
    CANCER MEDICINE, 2020, 9 (06): : 2019 - 2029
  • [40] Role of immunotherapy in stage IV non-small cell lung cancer with liver metastasis: A NCDB analysis
    Komiya, Takefumi
    Takamori, Shinkichi
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345